Urinary Potassium Excretion and Risk of Developing Hypertension The Prevention of Renal and Vascular End-Stage Disease Study

被引:52
|
作者
Kieneker, Lyanne M. [1 ,2 ,4 ]
Gansevoort, Ron T. [2 ]
Mukamal, Kenneth J. [5 ]
de Boer, Rudolf A. [3 ]
Navis, Gerjan [2 ]
Bakker, Stephan J. L. [1 ,2 ]
Joosten, Michel M. [1 ,2 ]
机构
[1] Top Inst Food & Nutr, Wageningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands
[5] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA
关键词
diet; epidemiology; hypertension; potassium; primary prevention; risk factors; sodium; BLOOD-PRESSURE; NUTRITIONAL FACTORS; SODIUM-INTAKE; ELECTROLYTE EXCRETION; RACIAL-DIFFERENCES; ALBUMIN EXCRETION; ASSOCIATION; DIET; METAANALYSIS; POPULATION;
D O I
10.1161/HYPERTENSIONAHA.114.03750
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Previous prospective cohort studies on the association between potassium intake and risk of hypertension have almost exclusively relied on self-reported dietary data, whereas repeated 24-hour urine excretions, as estimate of dietary uptake, may provide a more objective and quantitative estimate of this association. Risk of hypertension (defined as blood pressure >= 140/90 mm Hg or initiation of blood pressure-lowering drugs) was prospectively studied in 5511 normotensive subjects aged 28 to 75 years not using blood pressure-lowering drugs at baseline of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study. Potassium excretion was measured in two 24-hour urine specimens at baseline (1997-1998) and midway during follow-up (2001-2003). Baseline median potassium excretion was 70 mmol/24 h (interquartile range, 57-85 mmol/24 h), which corresponds to a dietary potassium intake of approximate to 91 mmol/24 h. During a median follow-up of 7.6 years (interquartile range, 5.0-9.3 years), 1172 subjects developed hypertension. The lowest sex-specific tertile of potassium excretion (men: <68 mmol/24 h; women: <58 mmol/24 h) had an increased risk of hypertension after multivariable adjustment (hazard ratio, 1.20; 95% confidence interval, 1.05-1.37), compared with the upper 2 tertiles (P-nonlinearity = 0.008). The proportion of hypertension attributable to low potassium excretion was 6.2% (95% confidence interval, 1.7%-10.9%). No association was found between the sodium to potassium excretion ratio and risk of hypertension after multivariable adjustment. Low urinary potassium excretion was associated with an increased risk of developing hypertension. Dietary strategies to increase potassium intake to the recommended level of 90 mmol/d may have the potential to reduce the incidence of hypertension.
引用
收藏
页码:769 / +
页数:15
相关论文
共 50 条
  • [31] Blood Pressure Indexes and End-Stage Renal Disease Risk in Adults With Chronic Kidney Disease
    Bell, Emmy K.
    Gao, Liyan
    Judd, Suzanne
    Glasser, Stephen P.
    McClellan, William
    Gutierrez, Orlando M.
    Safford, Monika
    Lackland, Daniel T.
    Warnock, David G.
    Muntner, Paul
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (07) : 789 - 796
  • [32] Predictors of End-stage Renal Disease in the Urban Poor
    Hall, Yoshio N.
    Choi, Andy I.
    Xu, Ping
    Smith, Nicholas L.
    Boyko, Edward J.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2013, 24 (04) : 1686 - 1700
  • [33] HYPERTENSIVE END-STAGE RENAL-DISEASE IN BLACKS - THE ROLE OF END-STAGE RENAL-DISEASE SURVEILLANCE
    MCCLELLAN, W
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 25 - 30
  • [34] The Risk of Major Elective Vascular Surgical Procedures in Patients With End-Stage Renal Disease
    Gajdos, Csaba
    Hawn, Mary T.
    Kile, Deidre
    Henderson, William G.
    Robinson, Thomas
    McCarter, Martin
    Nehler, Mark
    ANNALS OF SURGERY, 2013, 257 (04) : 766 - 773
  • [35] Proenkephalin and the risk of new-onset heart failure: data from prevention of renal and vascular end-stage disease
    Emmens, Johanna E.
    ter Maaten, Jozine M.
    Brouwers, Frank P.
    Kieneker, Lyanne M.
    Damman, Kevin
    Hartmann, Oliver
    Schulte, Janin
    Bakker, Stephan J. L.
    de Boer, Rudolf A.
    Voors, Adriaan A.
    CLINICAL CARDIOLOGY, 2021, 44 (12) : 1662 - 1672
  • [36] History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease
    Calderon-Margalit, Ronit
    Golan, Eliezer
    Twig, Gilad
    Leiba, Adi
    Tzur, Dorit
    Afek, Arnon
    Skorecki, Karl
    Vivante, Asaf
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) : 428 - 438
  • [37] History of hypertension in patients treated for end-stage renal disease
    Perneger, TV
    Whelton, PK
    Klag, MJ
    JOURNAL OF HYPERTENSION, 1997, 15 (04) : 451 - 456
  • [38] Hypertension and End-Stage Renal Disease: Vital Understanding Needed
    Narsipur, Sriram S.
    JOURNAL OF PEDIATRICS, 2012, 160 (04) : 542 - 543
  • [39] Association of Adolescent Hypertension With Future End-stage Renal Disease
    Leiba, Adi
    Fishman, Boris
    Twig, Gilad
    Gilad, David
    Derazne, Estela
    Shamiss, Ari
    Shohat, Tamar
    Ron, Ofir
    Grossman, Ehud
    JAMA INTERNAL MEDICINE, 2019, 179 (04) : 517 - 523
  • [40] Hypertension and Future Cardiovascular Health in Pediatric End-Stage Renal Disease Patients
    Flynn, Joseph T.
    BLOOD PURIFICATION, 2012, 33 (1-3) : 138 - 143